United States · Platforms & data · MarketBeat
Guggenheim Has Lowered Expectations for Zevra Therapeutics (NASDAQ:ZVRA) Stock Price

Detailed summary
Guggenheim decreased their target price on shares of Zevra Therapeutics from $23.00 to $18.00 and set a "buy" rating on the stock in a research note on Monday.
MarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.marketbeat.com)




